16 Analysts Have This To Say About Globus Medical
16 Analysts Have This To Say About Globus Medical
16位分析師對Globus Medical的看法
In the preceding three months, 16 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish.
在之前的三個月中,16位分析師對Globus Medical(紐交所:GMED)發佈了評級,展現了從看好到看淡的各種觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下面的表格提供了他們最近評級的快照,展示了過去30天情緒的變化,並與前幾個月進行了比較。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $91.31, a high estimate of $115.00, and a low estimate of $78.00. Surpassing the previous average price target of $81.81, the current average has increased by 11.61%.
分析師評估的12個月價格目標揭示了進一步的見解,平均目標爲91.31美元,最高預估爲115.00美元,最低預估爲78.00美元。當前的平均價格目標已超過之前的平均價格目標81.81美元,增加了11.61%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查:一項詳盡的研究
The analysis of recent analyst actions sheds...
近期分析師行動...
登入免費觀看全文
登入/註冊